FVIII treatment update       SELECTED IMPORTANT SAFETY INFORMATION You should not use Kogenate® FS, Antihemophilic Factor (Recombinant) or Helixate® FS, Antihemophilic Factor (Recombinant) if you are allergic to rodents (like mice and hamsters) or are allergic to any ingredients in Kogenate FS or Helixate FS. Continue reading below             {{userPhoto}}   Because your treatment matters           {{userName}} Bayer Rep   {{userEmailAddress}} | {{User.Phone}}         Dear {{accTitle}} {{accFname}} {{accLname}}, {{customText[I just wanted to follow up with you. You mentioned you wanted to know more about the upcoming changes for Helixate FS and Kogenate FS. I wanted to send that information along.|It was great seeing you recently. I would like to share some additional information about Helixate FS and Kogenate FS that may be useful for you.|It was great seeing you recently. You said you had some questions about Helixate FS and Kogenate FS. I think you'll find this information useful.|I hope you are having a great day. I am following up on our previous conversation with the information you requested about Helixate FS and Kogenate FS.|It was great seeing you at the NHF meeting. I would like to share some additional information about Helixate FS and Kogenate FS.|It was great seeing you at the HFA meeting. I would like to share some additional information about Helixate FS and Kogenate FS.|It was great seeing you at the Texas Bleeds meeting. I would like to share some additional information about Helixate FS and Kogenate FS.|It was great seeing you at the FAM Ohio meeting. I would like to share some additional information about Helixate FS and Kogenate FS.|I hope all is well. It's been some time since we last spoke, but I would like to share some more helpful information about Helixate FS and Kogenate FS.]}} As you may already know, under a current supply agreement, Bayer manufactures Helixate FS and provides it to CSL Behring. However, this supply agreement between Bayer and CSL Behring is ending after Dec‌ember 3‌1, 2‌017, at which point Helixate FS will no longer be manufactured by Bayer—so all Helixate FS patients will need to transition to a different factor VIII product in the near future.         Continue your FVIII treatment with Kogenate FS         Some important information to know when considering this transition:       Kogenate FS and Helixate FS contain the same factor (active pharmaceutical ingredient and formulation) and are manufactured by Bayer in the same facility   Kogenate FS is covered by all major insurance companies and is preferred by CVS/Caremark,* Express Scripts,† and UnitedHealthcare*         This year, 7 out of 10 people who transitioned from Helixate FS treatment were prescribed Kogenate FS‡         We understand that change might be difficult and it may take some time to accept a new treatment. By starting the transition now, you will be able to avoid an abrupt change at the end of the year, and it will give you some time to adjust and learn about treatments and coverage. Bayer is committed to supporting you and the hemophilia A community with a variety of patient and community support programs.       Bayer Access Solutions§ offers insurance assistance, financial support, and trained Case Specialists to allow for a seamless transition     – Bayer Access Solutions includes Free Trial, Co-pay, and Loyalty Programs‖     – The Loyalty Program can help cover Kogenate FS at no cost during gaps in insurance coverage     – You can click here or call 1‑800‑288‑8374 8:‌00 am–8:‌00 pm (ET) Monday‌–‌Friday for more information or to enroll           To learn more, visit ContinueFactor.com       * On some commercial prescription plans. † This pertains to Express Scripts's National Preferred and Basic Formularies. ‡ Sources: Symphony Health claim database; specialty pharmacy aggregate data; 1/‌17 – 5/‌17. Percentage is derived from actual data from an existing data set, which may underestimate or overestimate actual percentage. § Restrictions apply. Please click here or call 1‑800‑288‑8374 for more information about the restrictions. ‖ Patients who have government insurance are not eligible for the loyalty and co-pay support programs.       INDICATIONS       Kogenate® FS Antihemophilic Factor (Recombinant) and Helixate® FS Antihemophilic Factor (Recombinant) are medicines used to replace clotting factor (factor VIII or antihemophilic factor) that is missing in people with hemophilia A.   Kogenate FS and Helixate FS are used to treat and control bleeding in adults and children with hemophilia A. Your healthcare provider may give you Kogenate FS or Helixate FS when you have surgery. Kogenate FS and Helixate FS can reduce the number of bleeding episodes in adults and children when used regularly (prophylaxis). Kogenate FS and Helixate FS can reduce the risk of joint damage in children without pre-existing joint damage when used regularly.   Kogenate FS and Helixate FS are not used to treat von Willebrand disease.       IMPORTANT SAFETY INFORMATION       You should not use Kogenate FS or Helixate FS if you are allergic to rodents (like mice and hamsters) or are allergic to any ingredients in Kogenate FS or Helixate FS.   Tell your healthcare provider if you have been told you have heart disease or are at risk for heart disease.   You could have an allergic reaction to Kogenate FS or Helixate FS. Call your healthcare provider right away and stop treatment if you get rash or hives, itching, tightness of the chest or throat, difficulty breathing, light-headed, dizziness, nausea or a decrease in blood pressure.   Your body can make antibodies, called "inhibitors," against Kogenate FS or Helixate FS, which may stop Kogenate FS or Helixate FS from working properly. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for the development of inhibitors to factor VIII.   Other common side effects of Kogenate FS and Helixate FS are local injection site reactions (pain, swelling, irritation at infusion site) and infections from implanted injection device. Tell your healthcare provider about any side effect that bothers you or does not go away.   Call your healthcare provider right away if bleeding is not controlled after using Kogenate FS or Helixate FS.       For additional important risk and use information, please see full Prescribing Information for Kogenate FS and Helixate FS. You are encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088. {{customText[If you'd like to have a more in-depth conversation, give me a call or reply to this email.|I hope this information helps. Please don't hesitate to call or email me if you are interested in more information or have any questions.|I would be happy to discuss this information with you in person. Feel free to contact me at the number below or reply to this email.]}}   Sincerely,   {{userName}} {{user.Phone}} Bayer Hematology           Bayer, the Bayer Cross, and Kogenate are registered trademarks of Bayer. Helixate FS is a registered trademark of CSL Behring LLC. © 2017 Bayer.       All rights reserved.       08/17       PP-675-US-2970 If you would like to contact us, please visit our Contact Us section online. 10‌0 Ba‌ye‌r Boul‌ev‌ard, PO Bo‌x 915, Whip‌pany, N‌J 07‌981-091‌5 USA Privacy Policy              Terms and Conditions              Unsubscribe